Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Christina Biaggi Rudolf"'
Autor:
Sergio Cogliatti, Visar Vela, Mario Bargetzi, Jakob Passweg, Qiyu Li, Thomas Pabst, Martin Fehr, Bob Löwenberg, Eugenia Haralambieva, Michael Medinger, Georg Stussi, Rainer Grobholz, Dominik Heim, Alexandar Tzankov, Pontus Lundberg, Magdalena M Brune, Christina Biaggi Rudolf, Luca Mazzuchelli, Yara Banz, Markus G. Manz, Gert J. Ossenkoppele
Publikováno v:
Brune, Magdalena M; Stüssi, Georg; Lundberg, Pontus; Vela, Visar; Heim, Dominik; Manz, Markus G; Haralambieva, Eugenia; Pabst, Thomas; Banz, Yara; Bargetzi, Mario; Grobholz, Rainer; Fehr, Martin; Cogliatti, Sergio; Ossenkoppele, Gert J; Löwenberg, Bob; Rudolf, Christina Biaggi; Li, Qiyu; Passweg, Jakob; Mazzuchelli, Luca; Medinger, Michael; ... (2021). Effects of lenalidomide on the bone marrow microenvironment in acute myeloid leukemia: Translational analysis of the HOVON103 AML/SAKK30/10 Swiss trial cohort. Annals of hematology, 100(5), pp. 1169-1179. Springer-Verlag 10.1007/s00277-021-04467-2
Annals of Hematology
on behalf of the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON) and Swiss Group for Clinical Cancer Research (SAKK) 2021, ' Effects of lenalidomide on the bone marrow microenvironment in acute myeloid leukemia: Translational analysis of the HOVON103 AML/SAKK30/10 Swiss trial cohort ', Annals of Hematology, vol. 100, no. 5, pp. 1169-1179 . https://doi.org/10.1007/s00277-021-04467-2
Annals of Hematology, 100(5), 1169-1179. Springer Verlag
Annals of Hematology
on behalf of the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON) and Swiss Group for Clinical Cancer Research (SAKK) 2021, ' Effects of lenalidomide on the bone marrow microenvironment in acute myeloid leukemia: Translational analysis of the HOVON103 AML/SAKK30/10 Swiss trial cohort ', Annals of Hematology, vol. 100, no. 5, pp. 1169-1179 . https://doi.org/10.1007/s00277-021-04467-2
Annals of Hematology, 100(5), 1169-1179. Springer Verlag
This translational study aimed at gaining insight into the effects of lenalidomide in acute myeloid leukemia (AML). Forty-one AML patients aged 66 or older of the Swiss cohort of the HOVON-103 AML/SAKK30/10 study were included. After randomization, t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8aa12e54d3654822cd1e3efdfa25700d
https://boris.unibe.ch/159234/1/Brune2021_Article_EffectsOfLenalidomideOnTheBone.pdf
https://boris.unibe.ch/159234/1/Brune2021_Article_EffectsOfLenalidomideOnTheBone.pdf